PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 10, 2026International Journal of Environmental Research and Public Health0 citationsOpen Access

Evolving Cancer Characteristics Among World Trade Center Survivors: An Updated Analysis from the WTC Environmental Health Center

View Full Paper
NDNedim DurmuşNew York City Health and Hospitals CorporationZWZiyue WangNew York UniversityAAAlan A. ArslanNYU Langone Health

Key Points

  • This analysis aims to describe the evolving cancer characteristics among World Trade Center survivors based on updated data.
  • Analyzed 7643 eligible primary cancers from 7274 WTC survivors with certifiable cancer diagnoses as of December 31, 2024
  • Utilized the WTC EHC Pan Cancer Database to summarize demographics, exposure history, and tumor characteristics
  • Examined the incidence of solid tumors and hematopoietic malignancies among the cohort.
  • Solid tumors comprised 87% of all certifications, with breast (22%) and prostate (19%) cancers being the most common
  • Median latency for cancer development was around 14–16 years, with 14% of survivors developing multiple primary cancers
  • The number of enrolled cancers increased 2.5-fold compared to the previous report in 2020.

Abstract

Local community populations (“survivors”) exposed to the World Trade Center (WTC) disaster experienced complex exposures to mixtures of dust and combustion products with potential carcinogenic effects. Survivors with certifiable WTC-related conditions are eligible for inclusion in the federally funded WTC Health Program. We provide an updated description of cancers in the WTC Environmental Health Center (EHC), a program for WTC survivors, through 31 December 2024. Using data from the WTC EHC Pan Cancer Database, we summarized demographics, exposure history, and tumor characteristics among enrollees with pathologically confirmed primary cancers meeting WTC Health Program certification criteria. Among 17,449 members, 7274 had a certifiable cancer diagnosis; excluding non-melanoma skin cancers, 6588 patients with 7643 eligible cancers were analyzed. Women comprised 50.3% of the cohort and 47.5% of diagnoses. Solid tumors accounted for 87% of certifications, with breast (22%) and prostate (19%) cancers most frequent, followed by lung (8%), thyroid (6%), colorectal (6%), and melanoma (4.5%). Lymphoproliferative and hematopoietic malignancies represented 13% of cases. Fourteen percent developed multiple primary cancers, and median latency clustered around 14–16 years. Compared with our previous report in 2020, the enrolled number of cancers increased 2.5-fold. These findings support the need for sustained surveillance and additional epidemiologic studies to improve cancer prevention and survivorship in this uniquely exposed population.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Durmuş et al. (2026) studied this question.

synapsesocial.com/papers/6a00217ac8f74e3340f9c54ehttps://doi.org/10.3390/ijerph23050625
Ask AI
Helpful
Bookmark
Share
View Full Paper